OA09631A - Interleukin-1 inhibitors - Google Patents

Interleukin-1 inhibitors

Info

Publication number
OA09631A
OA09631A OA59901A OA59901A OA09631A OA 09631 A OA09631 A OA 09631A OA 59901 A OA59901 A OA 59901A OA 59901 A OA59901 A OA 59901A OA 09631 A OA09631 A OA 09631A
Authority
OA
OAPI
Prior art keywords
interleukin
inhibitors
Prior art date
Application number
OA59901A
Inventor
Charles H Hannoum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of OA09631A publication Critical patent/OA09631A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA59901A 1988-05-27 1990-11-23 Interleukin-1 inhibitors OA09631A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03

Publications (1)

Publication Number Publication Date
OA09631A true OA09631A (en) 1993-04-30

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59901A OA09631A (en) 1988-05-27 1990-11-23 Interleukin-1 inhibitors

Country Status (9)

Country Link
JP (2) JP3192651B2 (en)
KR (1) KR970002917B1 (en)
BR (1) BR8907457A (en)
DK (1) DK172763B1 (en)
FI (2) FI109206B (en)
HU (3) HU222810B1 (en)
NO (2) NO316122B1 (en)
OA (1) OA09631A (en)
WO (1) WO1989011540A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
WO1991017249A1 (en) * 1990-05-01 1991-11-14 Cetus Corporation Interleukin-1 antagonist and uses thereof
US5824549A (en) * 1990-10-09 1998-10-20 Chiron Corporation Transformed human T cell
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
AU2002346882A1 (en) * 2001-10-26 2003-05-06 Novartis Ag Methods for the treatment of osteoarthritis and compositions thereof
EP1494714A4 (en) 2002-04-05 2008-03-05 Amgen Inc Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
ES2414460T3 (en) 2004-08-04 2013-07-19 Amgen Inc. Antibodies for Dkk-1
RS56743B1 (en) 2007-08-21 2018-03-30 Amgen Inc Human c-fms antigen binding proteins
JP5976319B2 (en) * 2008-09-12 2016-08-23 エックスバイオテク,インコーポレイテッドXbiotech,Inc. Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
CA2828504A1 (en) 2011-03-14 2012-09-20 Serodus Asa Antagonists of the interleukin-1 receptor
CA2833147A1 (en) 2011-04-15 2012-10-18 Anita SESHIRE Anti- il-1r1 inhibitors for use in cancer
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
KR102380150B1 (en) 2016-03-08 2022-03-29 얀센 바이오테크 인코포레이티드 GITR Antibodies, Methods, and Uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633471B2 (en) * 1987-08-26 1993-02-04 Biogen Idec Ma Inc. Biological materials, processes for producing biological materials and for using such materials in therapy

Also Published As

Publication number Publication date
FI109206B (en) 2002-06-14
HU9803037D0 (en) 1999-11-29
AU633831B2 (en) 1993-02-11
NO905090L (en) 1991-01-28
NO20014783L (en) 1991-01-28
JP2001029093A (en) 2001-02-06
JPH03505279A (en) 1991-11-21
KR970002917B1 (en) 1997-03-12
HU215434B (en) 1999-04-28
DK8591A (en) 1991-01-18
FI905812A0 (en) 1990-11-26
NO316917B1 (en) 2004-06-21
HU222810B1 (en) 2003-11-28
JP3192651B2 (en) 2001-07-30
NO905090D0 (en) 1990-11-23
HU893412D0 (en) 1991-05-28
NO20014783D0 (en) 2001-10-01
DK172763B1 (en) 1999-07-05
BR8907457A (en) 1991-04-02
AU3746989A (en) 1989-12-12
NO316122B1 (en) 2003-12-15
DK8591D0 (en) 1991-01-18
WO1989011540A1 (en) 1989-11-30
FI20020545A (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU7683391A (en) Modified interleukin-1 inhibitors
HU9803037D0 (en) Interleukin-1 inhibitors
YU208688A (en) Vice
GR862032B (en) Dopamine-b-hydroxylase inhibitors
HU906389D0 (en) New alpha-glycosidase inhibitors
ZA868269B (en) Dipamine-beta-hydroxylase inhibitors
ZA899924B (en) Renin inhibitors
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
GB8808176D0 (en) Centre finding tapemeasure
GB8807572D0 (en) Octafluorobiphenyls
IE882591L (en) Interleukin-1 inhibitors
ZA894052B (en) Interleukin-1 inhibitors
GB2223701B (en) Nut
GR860362B (en) Dopamine -b-hydroxylase inhibitors
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE880785L (en) Inhibitors of interleukin-1 release
BG46057A1 (en) Oureasive activity inhibitor
IE883871L (en) Dobamine-beta-hydroxylase inhibitors.
IE872276L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE860327L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE862056L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE880860L (en) Dopamine-beta-hydroxylase inhibitors
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
CA60525S (en) Cheeseboard
GB8917507D0 (en) Spanner